Sunnybrook Health Sciences Centre
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sunnybrook.ca
Unrestricted Rehabilitation Following Primary THA
- Conditions
- Interventions
- First Posted Date
- 2014-03-05
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 10
- Registration Number
- NCT02079467
- Locations
- 🇨🇦
Holland Orthopaedic and Arthritic Centre, Toronto, Ontario, Canada
Recovery Improved in Covert Stroke With Exercise
- Conditions
- Interventions
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 39
- Registration Number
- NCT02068391
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)
- Conditions
- Interventions
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 1
- Registration Number
- NCT02038816
- Locations
- 🇨🇦
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2014-01-16
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 100
- Registration Number
- NCT02037464
- Locations
- 🇨🇦
Sunnybrook Hospital, Toronto, Ontario, Canada
The Impact of a Patient Education Intervention for Ambulatory Oncology Patients
- Conditions
- Interventions
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2014-09-08
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 96
- Registration Number
- NCT02038114
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 24
- Registration Number
- NCT02036086
- Locations
- 🇨🇦
The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
🇨🇦Royal Victoria Hospital, Montreal, Quebec, Canada
🇨🇦Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Driving in Mild Dementia Decision Tool
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 69
- Registration Number
- NCT02036099
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial
- Conditions
- Interventions
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2014-01-14
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 150
- Registration Number
- NCT02036008
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
- Conditions
- Interventions
- First Posted Date
- 2014-01-14
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 40
- Registration Number
- NCT02035982
- Locations
- 🇨🇦
North York General Hospital, Toronto, Ontario, Canada
🇨🇦Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 30
- Registration Number
- NCT02031328
- Locations
- 🇨🇦
Sunnybrook Health Science Centre Odette Cancer Centre, Toronto, Ontario, Canada